Elevation of fatty acid-binding protein 4 is predisposed by family history of hypertension and contributes to blood pressure elevation
about
Serum FABP5 concentration is a potential biomarker for residual risk of atherosclerosis in relation to cholesterol efflux from macrophagesA-FABP concentration is more strongly associated with cardiometabolic risk factors and the occurrence of metabolic syndrome in premenopausal than in postmenopausal middle-aged womenSerum fatty acid-binding protein 4 (FABP4) concentration is associated with insulin resistance in peripheral tissues, A clinical study.Elevation of circulating fatty acid-binding protein 4 is independently associated with left ventricular diastolic dysfunction in a general population.Urinary excretion of fatty acid-binding protein 4 is associated with albuminuria and renal dysfunction.Determining the binding affinity of therapeutic monoclonal antibodies towards their native unpurified antigens in human serum.Fatty Acid-Binding Protein 4 (FABP4): Pathophysiological Insights and Potent Clinical Biomarker of Metabolic and Cardiovascular Diseases.Circulating levels of fatty acid-binding protein family and metabolic phenotype in the general populationCirculating Adipocyte Fatty Acid Binding Protein (FABP4) Levels Are Associated with Irisin in the Middle-Aged General Chinese Population.Possible Increase in Serum FABP4 Level Despite Adiposity Reduction by Canagliflozin, an SGLT2 Inhibitor.Transcriptome and Metabolome Analyses in Exogenous FABP4- and FABP5-Treated Adipose-Derived Stem CellsReduction of serum FABP4 level by sitagliptin, a DPP-4 inhibitor, in patients with type 2 diabetes mellitus.Reduction of circulating FABP4 level by treatment with omega-3 fatty acid ethyl esters.Gene Expression Profile of Persistent Postoperative Hypertension Patients with Aldosterone-producing AdenomasCirculating Adipokines and Vascular Function: Cross-Sectional Associations in a Community-Based Cohort.IL-1β, RAGE and FABP4: targeting the dynamic trio in metabolic inflammation and related pathologies.RNA-seq analysis of the kidneys of broiler chickens fed diets containing different concentrations of calcium.Ectopic Fatty Acid-Binding Protein 4 Expression in the Vascular Endothelium is Involved in Neointima Formation After Vascular Injury.Angiotensin II receptor blockers decrease serum concentration of fatty acid-binding protein 4 in patients with hypertension.FABP4 is secreted from adipocytes by adenyl cyclase-PKA- and guanylyl cyclase-PKG-dependent lipolytic mechanisms.Chronic liquid nutrition intake induces obesity and considerable but reversible metabolic alterations in Wistar rats.Vasculo-protective effect of BMS-309403 is independent of its specific inhibition of fatty acid-binding protein 4.New insight into determining indicators of metabolic status in women: Expression of PPARγ and FABP4 in PBMCs.Plasma fatty acid-binding protein 4 (FABP4) as a novel biomarker to predict gestational diabetes mellitus.Lipocalin-2, A-FABP and inflammatory markers in relation to flow-mediated vasodilatation in patients with essential hypertension.Common variants associated with changes in levels of circulating free fatty acids after administration of glucose-insulin-potassium (GIK) therapy in the IMMEDIATE trial.
P2860
Q33669547-06CAB0CE-730A-4245-92B6-D49544553FC1Q33757446-5CCD5EBF-4EB6-4961-8542-AF11012D516EQ33842279-A1B542F7-FCCB-4CA8-8D2E-AF828B21BB0DQ34103605-5BD92A8E-5B54-4575-B67E-BCA900B68475Q34704298-7BA3D002-23DD-4747-BEC0-428F78F0A12CQ35040430-41DDF5AA-04C6-4E62-BE9F-666CB0C46680Q35042217-8F29CBBD-BC21-47C0-A28B-06BE9D37AADFQ35054010-C20800F2-9B55-4545-BC4B-7946636A256EQ35890419-02B2B6DB-6B1F-48B1-96BF-D7273CC541DEQ36001903-1C662584-0F9D-4E1D-8B3E-24FA52758C20Q36218431-D02A64A4-7CAC-44CF-B583-029B890C2260Q36307279-CFE5C159-7E05-47B0-BEC1-7D8A0551AD61Q36454709-F02725A8-A35A-43BD-92CA-8F1207D6A23CQ36523167-25ABE16E-0B85-46D0-B177-57AAED0C5F2EQ36837460-269438E2-32EA-4B50-92C2-E52F41747F58Q37305013-2039867E-8040-4C09-8437-1D2360DC901DQ41717850-2B431B2B-2EEF-443E-8ED1-7FDE19F465ADQ42373725-C01F7E4C-533D-4D37-A480-5264647159F5Q42830503-57F640F4-2E1D-4C56-A88D-DEE6EA8AE672Q42832081-E4FB6712-EA04-4B63-A233-E07474C9F36EQ50529797-B4DF9AC0-7DD1-43D7-AF4F-EE036975DC6FQ50730906-21045C67-73C4-40DE-BC89-636D6F5F1C8CQ51279946-A35E96E9-F86F-4673-8EFD-F01CD293A86CQ51285040-1EEF945C-3985-407A-BB3D-B647A6F083C0Q51327558-3C3DFE74-403F-405D-B049-F0C61CA5480EQ53257055-18280D21-5D11-4B78-9B99-594F2315EF79
P2860
Elevation of fatty acid-binding protein 4 is predisposed by family history of hypertension and contributes to blood pressure elevation
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Elevation of fatty acid-bindin ...... es to blood pressure elevation
@ast
Elevation of fatty acid-bindin ...... es to blood pressure elevation
@en
type
label
Elevation of fatty acid-bindin ...... es to blood pressure elevation
@ast
Elevation of fatty acid-bindin ...... es to blood pressure elevation
@en
prefLabel
Elevation of fatty acid-bindin ...... es to blood pressure elevation
@ast
Elevation of fatty acid-bindin ...... es to blood pressure elevation
@en
P2093
P2860
P356
P1476
Elevation of fatty acid-bindin ...... es to blood pressure elevation
@en
P2093
Hideaki Yoshida
Hideki Ota
Kazuaki Shimamoto
Marenao Tanaka
Masato Furuhashi
Masayuki Koyama
Shutaro Ishimura
Takahiro Fuseya
Tetsuji Miura
Tomohiro Mita
P2860
P304
P356
10.1038/AJH.2012.88
P577
2012-06-21T00:00:00Z